INT242749

Context Info Confidence 0.07 First Reported 2008 Last Reported 2008 Negated 0 Speculated 0 Reported most in Body Documents 1 Total Number 1 Disease Relevance 0.34 Pain Relevance 0.56

peptidase activity (Naalad2) cellular_component (Naalad2)

Naalad2 (Mus musculus)

Pain Link Frequency Relevance Heat Intracerebroventricular 15 99.98 Analgesic 12 85.64 antagonist 6 76.16 agonist 8 72.12 Eae 14 64.76 intrathecal 2 64.40 Pain 19 58.72 Inflammation 5 56.08 analgesia 17 11.20 addiction 1 8.16

Disease Link Frequency Relevance Heat Inflammatory Pain 12 64.76 Pain 19 58.72 INFLAMMATION 5 56.08 Neuropathic Pain 4 54.96 Bone Cancer 2 53.68 Akathisia 1 39.40 Nociception 3 5.00 Urological Neuroanatomy 2 5.00 Overdose 1 5.00 Toxicity 1 5.00

Sentences Mentioned In

Key:

Protein

Mutation

Event

Anatomy

Negation

Speculation

Pain term

Disease term

Similarly, ICV injection of NAAG itself decreased the sum of flinches, in both phases of the flinching behavior in a dose-dependent manner between 1 and 10 ?

Negative_regulation (decreased) of NAAG Binding (injection) of associated with intracerebroventricular

1) Confidence 0.07 Published 2008 Journal Mol Pain Section Body Doc Link PMC2517065 Disease Relevance 0.34 Pain Relevance 0.56

General Comments

This test has worked.